Gennex Laboratories has scheduled a Board of Directors meeting for Friday, September 4, 2026. The session will be held at its corporate office in Hyderabad.

The primary agenda item involves deciding regarding the conduct of the company's 41st Annual General Meeting for the year ended March 31, 2026.

Meeting Agenda

The board will also consider the appointment of a scrutinizer for the AGM, contingent upon the finalization of the meeting date. Any other business may be discussed with the permission of the Chairperson.

This intimation is issued pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015. The company has uploaded the notice on its official website.

Gennex Laboratories reported a 31% year-on-year increase in standalone revenue from operations to ₹36.67 crore for the quarter ended June 30, 2026. This marks a significant acceleration from the ₹27.90 crore logged in Q1FY26. However, profitability contracted slightly, with net profit after tax falling 4% to ₹3.96 crore compared to ₹4.15 crore in the prior year period.

The Board of Directors approved the unaudited standalone and consolidated financial results during its meeting held on August 14, 2026. The results were subsequently published in Business Standard and Saksham on August 15, 2026, in compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance

Standalone revenue from operations rose to ₹36.67 crore from ₹27.90 crore in Q1FY26. In the preceding quarter (Q4FY26), revenue stood at ₹38.01 crore, indicating a sequential dip of approximately 4%. Consolidated revenue from operations increased 15% year-on-year to ₹41.85 crore, up from ₹36.45 crore in Q1FY26.

Net profit before tax on a standalone basis declined 13% to ₹4.21 crore from ₹4.85 crore in the same quarter last year. After-tax net profit fell 4% to ₹3.96 crore. On a consolidated basis, net profit after tax dropped 7% to ₹4.67 crore from ₹5.02 crore in Q1FY26.

Earnings per share (basic) on a standalone basis were ₹0.163, down from ₹0.179 in Q1FY26. Consolidated basic EPS was ₹0.192, compared to ₹0.217 in the previous year.

What the Numbers Show

The divergence between revenue growth and profit contraction highlights margin pressure during the quarter. While standalone revenue surged 31%, net profit before tax fell 13%. This suggests that costs or expenses grew at a faster rate than top-line sales, compressing operational efficiency relative to the prior year period. The sequential decline in revenue from ₹38.01 crore in Q4FY26 to ₹36.67 crore in Q1FY27 further indicates potential seasonality or normalization in demand post-fiscal year end.